Australian Genome Research Facility

Name

Australian Genome Research Facility

Legal name

Australian Genome Research Facility Ltd.

Website

https://agrf.org.au

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

101–250 employees

Ownership category

akta.pro rank

Product category

Genomic Laboratory Services

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Molecular Diagnostics & Genomics Laboratories (HLAFAMAE)

akta.pro secondary industries

Bioinformatics, Multi-Omics Data Analysis & Interpretation Services (HLAGANAI), Genetic & Genomic Testing (germline, somatic, carrier, pharmacogenomics) (HLAAALAD), Genomics & Molecular Diagnostics (Trial Support) (HLAGAEAD), Genomic Testing & Genetic Evaluation Services (AFAEAJAC), Molecular Breeding & Marker-Assisted Selection (MAS) (AFABALAD)

Keywords

• Genomic sequencing services
• Clinical genomics testing
• Bioinformatics analysis
• DNA sequencing laboratory
• Multi-omic services

Headquarters

HQ city

Melbourne

HQ country

Australia

HQ region

Oceania

Offices4 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Infrastructure, Technology or R&D, Operations, Supply Chain

Revenue model

1. Genomic Services: AGRF generates revenue through providing genomic sequencing and analysis services including DNA/RNA extraction, next generation sequencing, array genotyping, long-read sequencing, Sanger sequencing, bioinformatics, and Olink proteomics. Services are priced via quotes and are available to academia, healthcare, and commercial industries.

Pricing tiers

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

AGRF is Australia's national genomics service provider offering end-to-end multi-omic services including DNA/RNA extraction, next generation sequencing (Illumina NovaSeq X Plus), PacBio long-read sequencing, Sanger sequencing, array genotyping, bioinformatics analysis, and Olink proteomics. The company delivers NATA-accredited clinical genomics (ISO15189) plus research and commercial genomics solutions across a national network of laboratories in Melbourne, Perth, Brisbane, and Sydney, serving academia, healthcare providers, pharmaceutical companies, and agricultural/environmental clients.

Product overview

AGRF is Australia's national genomics service provider offering a comprehensive suite of multi-omic services organized across three tiers: (1) Core genomic services including Next Generation Sequencing (NovaSeq X Plus), PacBio Long-Read Sequencing, Sanger Sequencing, DNA/RNA Extraction, Genotyping (Illumina arrays), and Advanced Genomics (chromatin mapping, pangenomes, Hi-C); (2) Proteomics via Olink certified partnerships providing Explore HT and Explore 3072 workflows; (3) Bioinformatics for data analysis and interpretation; (4) Clinical solutions including Whole Genome Sequencing, Whole Exome Sequencing, Clinical Panels, and Carrier Screening Assays (all ISO15189/NATA accredited). Additional application areas span agriculture, environmental science, microbiome, drug discovery, and genetic ID. The company operates as a service laboratory rather than a software product, providing end-to-end solutions from sample extraction through data delivery.

Differentiator

Problem solved

Functional benefit

Products and services

• Next Generation Sequencing High-throughput DNA/RNA sequencing service using Illumina NovaSeq X Plus technology for whole genome, exome, transcriptome, and targeted sequencing applications.
• PacBio Long-Read Sequencing Single-molecule real-time (SMRT) sequencing on PacBio Revio systems producing high-fidelity (HiFi) long-read data for reference-quality genome assembly, microbial profiling, and full-length transcriptomics.
• Sanger Sequencing Gold-standard capillary sequencing service for single-gene analysis, validation, and targeted applications requiring high accuracy.
• DNA/RNA Extraction Sample preparation service for high-quality DNA and RNA extraction from various biological sample types.
• Genotyping Array-based genotyping service using Illumina platforms including Global Screening Array, EPIC array, and custom content for population genetics, GWAS, methylation screening, and clinical applications.
• Olink Proteomics Olink certified service providing proteomics workflows including Explore HT (5,416 proteins) and Explore 3072 panels for biomarker discovery using proximity extension assay technology.
• Bioinformatics Comprehensive data analysis service including genome assembly, variant calling, annotation, methylation analysis, transcriptomics, and custom bioinformatics pipelines.
• Advanced Genomics Specialized genomic services including chromatin mapping (CUT&RUN, CUT&Tag, Fiber-Seq), pangenome assembly, and 3D genomics using Hi-C technologies.
• Clinical Whole Genome Sequencing NATA-accredited (ISO15189) whole genome sequencing for clinical diagnostics with comprehensive bioinformatics and clinical reporting.
• Whole Exome Sequencing Targeted sequencing of protein-coding regions for clinical variant discovery with ISO15189 accreditation.
• Clinical Panels Disease-specific gene panels for clinical diagnostics across various hereditary conditions.
• Carrier Screening Assays Genetic screening tests to identify carriers of hereditary genetic conditions.
• Genetic ID Genomic identification service for species authentication, provenance tracing, and forensic applications.
• Microbiome Services Metagenomic profiling and microbial community analysis for environmental, clinical, and research applications.

Quantifiable outcome

• 2-year survival more than double for children receiving ZERO-recommended treatment vs standard therapy
• +1 more outcomes

Named customers13 records

Segments7 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability4 records

Feature4 records

Partnerships

Eleven partnerships are on record, tiered core and flagship.

• ARC Centre of Excellence in Plants for Space (P4S)coreStrategic or Co-development Partner · 4 October 2023AGRF partners with P4S led by University of Adelaide to develop technologies for sustainable plant-based life support systems for space settlements. AGRF contributes 25 years of genomics expertise to improve and characterise plants designed for space.
• Children's Cancer Institute / Zero Childhood Cancer ProgramflagshipStrategic or Co-development Partner · 16 September 2021AGRF is a key partner in the Zero Childhood Cancer Program, Australia's first national precision medicine program for children with cancer. AGRF provides extensive multi-omic sequencing data (Whole Genome Sequencing and RNA Sequencing) for each child enrolled in the program. The program brings together all major Australian children's hospitals and 22 research partners.
• Professor Glenn King, University of QueenslandcoreTechnology or Integration · 8 February 2021PacBio ANZ HiFi SMRT Grant recipient studying Australian box jellyfish genome. Project integrates genome, transcriptome and proteome data to investigate venom function and evolution, potentially developing improved antivenoms.
• Professor Rajeev Varshney, Murdoch UniversitycoreStrategic or Co-development PartnerPartnership to build wheat pangenomes for ten commercially valuable wheat varieties. Project uses PacBio HiFi contigs and Omni-C 3D data for chromosome-level assembly to improve understanding of crop genetic diversity for drought tolerance, disease resistance, and grain quality.
• Australian Academy of Science / Ukraine-Australia Research FundcoreStrategic or Co-development PartnerAGRF provides genomics services to support Ukrainian researcher Dr Iryna Kozeretska in sequencing genomes of Antarctic fairy shrimp and copepod to understand climate change adaptations. AGRF provides extra services at no cost complementing Academy funding.
• SeonixBiocoreStrategic or Co-development PartnerPartnership to develop and clinically implement a genetic risk prediction test for glaucoma using Global Screening Array testing and customized bioinformatics for polygenic risk scores. AGRF supported NATA accreditation, extraction protocols, and bioinformatics infrastructure.
• Ketim TechnologiescoreStrategic or Co-development PartnerAGRF supports Ketim Technologies in developing the world's first clinical blood test for postpartum depression using Olink proteomics biomarker analysis to uncover molecular signals linked to PPD.
• CRC-TiME (Cooperative Research Centre for Transformations in Mining Economies)coreStrategic or Co-development PartnerCollaboration to provide data supporting innovative strategies for climate-resilient mine rehabilitation. AGRF develops soil microbiome profiling technology using Next-Generation Sequencing to create 'land memory' tools for decision-making in site restoration.
• ARC Industrial Transformation Research Hub for Advanced Prawn BreedingcoreStrategic or Co-development PartnerPartnership with James Cook University, CSIRO, University of Sydney, and Seafarms Group to apply cutting-edge genetic and genomic selection for prawn breeding. Successfully mapped black tiger prawn genome.
• Dr Carolyn Hogg, University of SydneycoreStrategic or Co-development PartnerThreatened Species Initiative partnership to create genomic resources for Australian threatened species. AGRF was first organisation in Australia to receive PacBio Sequel II system.
• NCRIS / Bioplatforms AustraliaflagshipStrategic or Co-development PartnerAGRF is an NCRIS supported facility under Bioplatforms Australia, providing access to leading infrastructure capabilities for Australian researchers.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Genomics England: UK government-backed national genomics program running large-scale clinical sequencing infrastructure; analogous in mandate and funding model to AGRF's NCRIS-supported national facility role and a useful benchmark for population-scale genomics.
• Macrogen: Korea-headquartered global genomics services company offering NGS, Sanger, and clinical sequencing; another broad incumbent competing with AGRF for international research and clinical genomics contracts.
• BGI Genomics: World-scale genomics services provider with DNBSEQ and multi-omic offerings; competes with AGRF on large population genomics, agricultural genomics, and high-volume clinical sequencing, often at lower per-sample cost.
• Eurofins Genomics: Global commercial genomics laboratory offering Sanger sequencing, NGS, oligonucleotides, and genotyping services; a broad incumbent competing with AGRF on standard molecular biology services for academic and commercial customers.
• HudsonAlpha Institute for Biotechnology: US non-profit genomics and bioinformatics provider operating clinical sequencing, research services, and CLIA-certified diagnostics; comparable to AGRF as a publicly-supported multi-omic service facility with a clinical arm.
• Novogene: Global NGS service provider offering Illumina and PacBio sequencing at high volume; competes with AGRF on price-sensitive research sequencing and large-scale international projects that can be routed offshore.

Regional players

• Translational Research Institute (TRI) Brisbane: Australian translational research institute co-located with AGRF's Brisbane facility; a peer in providing translational research infrastructure (genomics-adjacent) within the same Australian academic ecosystem, though not a direct sequencing competitor.

Direct peers

• Genome.One: Australian clinical genomics service provider offering whole genome sequencing and rare disease diagnostics; the closest domestic competitor to AGRF's NATA-accredited clinical pipeline and a direct peer for Australian patient-facing genomics.
• Garvan Institute of Medical Research (Kinghorn Centre for Clinical Genomics): Australian genomic medicine provider operating clinical-grade sequencing and bioinformatics for research and clinical diagnostics; competes with AGRF for NSW-based clinical and translational genomics contracts.

Others

• Australian BioCommons: Australian national bioinformatics and computational biology capability platform co-funded via Bioplatforms Australia/NCRIS; not a sequencing lab itself, but a closely related enabling ecosystem participant that complements AGRF's bioinformatics service layer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/AGRF_genomics

Compliance9 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Australian Genome Research Facility